MED-RIVASTIGMINE DIN 02401622
Status: Marketed
Holder: GENERIC MEDICAL PARTNERS INC
Health Canada record
| Active ingredient(s) | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06DA03 RIVASTIGMINE |
| Original market date | 27-Nov-2013 |
| Current status date | 27-Nov-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Generic Medical Partners Inc — licence 101749, currently licensed, last inspection rating C (2023-05-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02336731 | APO-RIVASTIGMINE | APOTEX INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Marketed |
| 02336758 | APO-RIVASTIGMINE | APOTEX INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Marketed |
| 02336723 | APO-RIVASTIGMINE | APOTEX INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Marketed |
| 02336715 | APO-RIVASTIGMINE | APOTEX INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Marketed |
| 02242116 | EXELON | KNIGHT THERAPEUTICS INC. | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Marketed |
| 02245240 | EXELON | KNIGHT THERAPEUTICS INC. | Solution | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 2 MG | Marketed |
| 02242118 | EXELON | KNIGHT THERAPEUTICS INC. | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Marketed |
| 02242117 | EXELON | KNIGHT THERAPEUTICS INC. | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Marketed |
| 02242115 | EXELON | KNIGHT THERAPEUTICS INC. | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Marketed |
| 02485397 | JAMP RIVASTIGMINE | JAMP PHARMA CORPORATION | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Marketed |
| 02485389 | JAMP RIVASTIGMINE | JAMP PHARMA CORPORATION | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Marketed |
| 02485370 | JAMP RIVASTIGMINE | JAMP PHARMA CORPORATION | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Marketed |
| 02485362 | JAMP RIVASTIGMINE | JAMP PHARMA CORPORATION | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Marketed |
| 02401614 | MED-RIVASTIGMINE | GENERIC MEDICAL PARTNERS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Marketed |
| 02401649 | MED-RIVASTIGMINE | GENERIC MEDICAL PARTNERS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Marketed |
| 02401630 | MED-RIVASTIGMINE | GENERIC MEDICAL PARTNERS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Marketed |
| 02427583 | AURO-RIVASTIGMINE | AURO PHARMA INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Dormant |
| 02427591 | AURO-RIVASTIGMINE | AURO PHARMA INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Dormant |
| 02427567 | AURO-RIVASTIGMINE | AURO PHARMA INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Dormant |
| 02427575 | AURO-RIVASTIGMINE | AURO PHARMA INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Dormant |
| 02307693 | DOM-RIVASTIGMINE | DOMINION PHARMACAL | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3.0 MG | Cancelled Pre Market |
| 02307685 | DOM-RIVASTIGMINE | DOMINION PHARMACAL | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Pre Market |
| 02307707 | DOM-RIVASTIGMINE | DOMINION PHARMACAL | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Pre Market |
| 02307715 | DOM-RIVASTIGMINE | DOMINION PHARMACAL | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6.0 MG | Cancelled Pre Market |
| 02407019 | MINT-RIVASTIGMINE | MINT PHARMACEUTICALS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02406985 | MINT-RIVASTIGMINE | MINT PHARMACEUTICALS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02406993 | MINT-RIVASTIGMINE | MINT PHARMACEUTICALS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
| 02407000 | MINT-RIVASTIGMINE | MINT PHARMACEUTICALS INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02332817 | MYLAN-RIVASTIGMINE | MYLAN PHARMACEUTICALS ULC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
| 02332809 | MYLAN-RIVASTIGMINE | MYLAN PHARMACEUTICALS ULC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02332825 | MYLAN-RIVASTIGMINE | MYLAN PHARMACEUTICALS ULC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02332833 | MYLAN-RIVASTIGMINE | MYLAN PHARMACEUTICALS ULC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02305992 | NOVO-RIVASTIGMINE | NOVOPHARM LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
| 02306026 | NOVO-RIVASTIGMINE | NOVOPHARM LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02305984 | NOVO-RIVASTIGMINE | NOVOPHARM LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02306018 | NOVO-RIVASTIGMINE | NOVOPHARM LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02308177 | PHL-RIVASTIGMINE | PHARMEL INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3.0 MG | Cancelled Pre Market |
| 02308193 | PHL-RIVASTIGMINE | PHARMEL INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6.0 MG | Cancelled Pre Market |
| 02308185 | PHL-RIVASTIGMINE | PHARMEL INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Pre Market |
| 02308169 | PHL-RIVASTIGMINE | PHARMEL INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Pre Market |
| 02306034 | PMS-RIVASTIGMINE | PHARMASCIENCE INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02306050 | PMS-RIVASTIGMINE | PHARMASCIENCE INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02306069 | PMS-RIVASTIGMINE | PHARMASCIENCE INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6.0 MG | Cancelled Post Market |
| 02306042 | PMS-RIVASTIGMINE | PHARMASCIENCE INC | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3.0 MG | Cancelled Post Market |
| 02311291 | RATIO-RIVASTIGMINE | TEVA CANADA LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
| 02311313 | RATIO-RIVASTIGMINE | TEVA CANADA LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02311283 | RATIO-RIVASTIGMINE | TEVA CANADA LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02311305 | RATIO-RIVASTIGMINE | TEVA CANADA LIMITED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02416999 | RIVASTIGMINE | PRO DOC LIMITEE | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02417006 | RIVASTIGMINE | PRO DOC LIMITEE | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
| 02417014 | RIVASTIGMINE | PRO DOC LIMITEE | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02417022 | RIVASTIGMINE | PRO DOC LIMITEE | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02375745 | RIVASTIGMINE TARTRATE CAPSULES | DR REDDY'S LABORATORIES LTD | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Pre Market |
| 02375729 | RIVASTIGMINE TARTRATE CAPSULES | DR REDDY'S LABORATORIES LTD | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Pre Market |
| 02375737 | RIVASTIGMINE TARTRATE CAPSULES | DR REDDY'S LABORATORIES LTD | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3.0 MG | Cancelled Pre Market |
| 02375753 | RIVASTIGMINE TARTRATE CAPSULES | DR REDDY'S LABORATORIES LTD | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6.0 MG | Cancelled Pre Market |
| 02324601 | SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 6 MG | Cancelled Post Market |
| 02324598 | SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 4.5 MG | Cancelled Post Market |
| 02324563 | SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 1.5 MG | Cancelled Post Market |
| 02324571 | SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Capsule | RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE) 3 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14148 | 2013-02-22 | Abbreviated New Drug Submission (ANDS) |